Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

2026 Mitsui Chemicals Catalysis Science Awards
2026 Mitsui Chemicals Catalysis Science Awards


Mitsui Chemicals, Inc. has announced that online applications for the 2026 Mitsui Chemicals Catalysis Science Award have been open since September 1, 2025. The application period will run from

EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Notice of the Revised Forecast of Consolidated Financials for FY2025 (IFRS)
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025


Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 (the

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025


Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 (the

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025


Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 (the

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025


Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 (the

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025


Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 (the

Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025
Mitsubishi UFJ Financial Group, Inc. Announces Filing of Annual Report on Form 20-F for the Year Ended March 31, 2025


Mitsubishi UFJ Financial Group, Inc. (NYSE:MUFG)(TOKYO:8306)(ISIN:JP3902900004)(MUFG) hereby announces that it has filed its Annual Report on Form 20-F for the fiscal year ended March 31, 2025 (the

ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025
ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025


ORIX Corporation (TOKYO: 8591; NYSE: IX; ISIN:JP3200450009) has submitted its annual Form 20-F for the fiscal year ended March 31, 2025 to the U.S. Securities and Exchange Commission on June 24

ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025
ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025


ORIX Corporation (TOKYO: 8591; NYSE: IX; ISIN:JP3200450009) has submitted its annual Form 20-F for the fiscal year ended March 31, 2025 to the U.S. Securities and Exchange Commission on June 24

ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025
ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025


ORIX Corporation (TOKYO: 8591; NYSE: IX; ISIN:JP3200450009) has submitted its annual Form 20-F for the fiscal year ended March 31, 2025 to the U.S. Securities and Exchange Commission on June 24

ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025
ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025


ORIX Corporation (TOKYO: 8591; NYSE: IX; ISIN:JP3200450009) has submitted its annual Form 20-F for the fiscal year ended March 31, 2025 to the U.S. Securities and Exchange Commission on June 24

ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025
ORIX Submits Form 20-F for Filing for the Fiscal Year Ended March 31, 2025


ORIX Corporation (TOKYO: 8591; NYSE: IX; ISIN:JP3200450009) has submitted its annual Form 20-F for the fiscal year ended March 31, 2025 to the U.S. Securities and Exchange Commission on June 24

Nomura Files Annual Report on Form 20-F
Nomura Files Annual Report on Form 20-F


Nomura Holdings, Inc. filed its Annual Report on Form 20-F (for the fiscal year ended March 31, 2025) with the U.S. Securities and Exchange Commission on June 24, 2025. The report can be accessed

Nomura Files Annual Report on Form 20-F
Nomura Files Annual Report on Form 20-F


Nomura Holdings, Inc. filed its Annual Report on Form 20-F (for the fiscal year ended March 31, 2025) with the U.S. Securities and Exchange Commission on June 24, 2025. The report can be accessed

Nomura Files Annual Report on Form 20-F
Nomura Files Annual Report on Form 20-F


Nomura Holdings, Inc. filed its Annual Report on Form 20-F (for the fiscal year ended March 31, 2025) with the U.S. Securities and Exchange Commission on June 24, 2025. The report can be accessed

Nomura Files Annual Report on Form 20-F
Nomura Files Annual Report on Form 20-F


Nomura Holdings, Inc. filed its Annual Report on Form 20-F (for the fiscal year ended March 31, 2025) with the U.S. Securities and Exchange Commission on June 24, 2025. The report can be accessed

Nomura Files Annual Report on Form 20-F
Nomura Files Annual Report on Form 20-F


Nomura Holdings, Inc. filed its Annual Report on Form 20-F (for the fiscal year ended March 31, 2025) with the U.S. Securities and Exchange Commission on June 24, 2025. The report can be accessed

Nomura Files Annual Report on Form 20-F
Nomura Files Annual Report on Form 20-F


Nomura Holdings, Inc. filed its Annual Report on Form 20-F (for the fiscal year ended March 31, 2025) with the U.S. Securities and Exchange Commission on June 24, 2025. The report can be accessed

Notice Regarding Conviction of Three Chinese Companies That Produced and Sold Counterfeit Yamaha PA Analog Mixers
Notice Regarding Conviction of Three Chinese Companies That Produced and Sold Counterfeit Yamaha PA Analog Mixers


Yamaha Corporation (hereinafter “Yamaha”) (TOKYO:7951) announces that on March 20, 2025, the Zhongshan Intermediate People's Court of Guangdong Province upheld the first-instance guilty verdicts in